1. Home
  2. VYX vs EVO Comparison

VYX vs EVO Comparison

Compare VYX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$7.22

Market Cap

980.9M

Sector

N/A

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.06

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYX
EVO
Founded
1881
1993
Country
United States
Germany
Employees
13500
4553
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.9M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VYX
EVO
Price
$7.22
$3.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$13.67
$7.00
AVG Volume (30 Days)
2.2M
47.1K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.02
$2.31
52 Week High
$14.67
$4.42

Technical Indicators

Market Signals
Indicator
VYX
EVO
Relative Strength Index (RSI) 55.89 56.03
Support Level $6.10 $2.88
Resistance Level $7.26 $3.75
Average True Range (ATR) 0.40 0.07
MACD -0.00 0.01
Stochastic Oscillator 48.80 89.58

Price Performance

Historical Comparison
VYX
EVO

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: